NHLBI Atherosclerosis Risk in Communities (ARIC) Candidate Gene Association Resource (CARe)

Request Access

Anthropometry (3)

Biomarkers (32)

  • apoa1 - Apolipoprotein A1 measurement in mg/L at designated visit (may not be from first visit) (phv00190341.v3.p3)
  • apob - Apolipoprotein B measurement in mg/L at designated visit (may not be from first visit) (phv00190343.v3.p3)
  • basophils - Basophils in absolute numbers at designated visit (may not be from first visit) (phv00190377.v3.p3)
  • cornell_voltage_ekg - Cornell voltage for EKG measurement (phv00190388.v3.p3)
  • crp - C-reactive protein level in mg/L at designated visit (may not be from first visit) (phv00190353.v3.p3)
  • dbp_baseline - Diastolic blood pressure (DBP) at first participant visit (avg. of 2 measurements), in mm Hg (phv00190317.v3.p3)
  • ekg_hr - HR interval from EKG at designated visit (may not be from first visit) (phv00190385.v3.p3)
  • ekg_pr - PR interval from EKG at designated visit (may not be from first visit) (phv00190384.v3.p3)
  • ekg_qrs - QRS interval from EKG at designated visit (may not be from first visit) (phv00190382.v3.p3)
  • ekg_qt - QT interval from EKG at designated visit (may not be from first visit) (phv00190383.v3.p3)
  • eosinophils - Eosinophils in absolute numbers at designated visit (may not be from first visit) (phv00190376.v3.p3)
  • factorVII - Factor VII level in % at designated visit (may not be from first visit) (phv00190347.v3.p3)
  • factorVIII - Factor VIII level in % at designated visit (may not be from first visit) (phv00190349.v3.p3)
  • fibrinogen - Fibrinogen level in mg/dL at first designated visit (may not be from first visit) (phv00190345.v3.p3)
  • hdl_baseline - High density lipoprotein (HDL) cholesterol level in mg/dL at first participant visit (phv00190312.v3.p3)
  • hematocrit - Hematocrit at designated visit (may not be from first visit) in % (phv00190365.v3.p3)
  • hemoglobin - Hemoglobin at designated visit (may not be from first visit) in g/dl (phv00190363.v3.p3)
  • icam1 - ICAM1 level in ng/mL at designated visit (may not be from first visit) (phv00190357.v3.p3)
  • il6 - IL6 level in pg/mL at designated visit (may not be from first visit) (phv00190355.v3.p3)
  • ldl_baseline - Baseline calculated low density lipoprotein (LDL) cholesterol in mg/dL (missing where trigs>400) (phv00190311.v3.p3)
  • lymphocytes - Lymphocytes in absolute numbers at designated visit (may not be from first visit) (phv00190375.v3.p3)
  • mean_corpuscular_volume - Mean corpuscular volume in femtoliters at designated visit (may not be from first visit) (phv00190367.v3.p3)
  • monocytes - Monocytes in absolute numbers at designated visit (may not be from first visit) (phv00190374.v3.p3)
  • neutrophils - Neutrophils in absolute numbers at designated visit (may not be from first visit) (phv00190373.v3.p3)
  • platelet_count - Platelet count at designated visit (may not be from first visit) in x 1000/cubic mm (phv00190368.v3.p3)
  • pselectin - P-selectin level at designated visit (may not be from first visit) (phv00190359.v3.p3)
  • red_blood_count - Red blood cell count (RBC) in million cells per microliter at designated visit (may not be from first visit) (phv00190371.v3.p3)
  • sbp_baseline - Systolic blood pressure (SBP) at first participant visit (avg. of 2 measurements), in mm Hg (phv00190316.v3.p3)
  • totchol_baseline - Total cholesterol level at first participant visit in mg/dL (phv00190314.v3.p3)
  • trigs_baseline - Triglyceride level at first participant visit in mg/dL (phv00190313.v3.p3)
  • vWF - VWF level in % at designated visit (may not be from first visit) (phv00190351.v3.p3)
  • wbc - White blood count in x1,000/cubic mm at designated visit (may not be from first visit) (phv00190361.v3.p3)

Demographics (24)

Disease Events (4)

  • angioplasty_baseline - History of angioplasty at first visit (0/1) (phv00190320.v3.p3)
  • cabg_baseline - History of coronary artery bypass (CABG) at first visit (0/1) (phv00190321.v3.p3)
  • mi_baseline - History of myocardial infarction (MI) recorded at first participant visit (0/1). (phv00190322.v3.p3)
  • t2diabetes_baseline - Type 2 diabetes (T2D) status at first participant visit (0/1) (phv00190306.v3.p3)

Geography (1)

Imaging (1)

  • imt_meanmean_farwall_cca - Average far wall thickness of the right and left common carotid mean intima media thickness (IMT) values, using as many views as are available for a given study (phv00190379.v3.p3)

Medications (2)

  • htn_med_baseline - Hypertension med status (any) at first participant visit (0/1) (phv00190319.v3.p3)
  • lipid_med_baseline - Any lipid lowering medication (statin or other) at first participant visit (phv00190315.v3.p3)

Race and Ethnicity (1)

Reproductive Health (1)

  • age_at_menarche - Age in years at menarche (start of menstruation) (phv00190336.v3.p3)

Respiratory (2)

  • fev1_first_avail_visit - Forced expiratory volume (FEV1) measurement at the first available visit (phv00190390.v3.p3)
  • fvc_first_avail_visit - Forced vital capacity (FVC) measurement at the first available visit (phv00190391.v3.p3)

Substance Use (2)

  • current_smoker_baseline - Current smoking status at first participant visit (0/1) (phv00190334.v3.p3)
  • former_smoker_baseline - Former smoking status at first participant visit (0/1) (phv00190335.v3.p3)

Other (24)

  • afib_baseline - History of atrial fibrillation at first participant visit (0/1) (phv00190329.v3.p3)
  • afib_during_followup - 0/1 to indicate that an atrial fibrillation occurred during study follow up. 0 if no afib during study follow up. 1 if an adjudicated afib occurred during study follow up. (phv00190330.v3.p3)
  • afib_tte_or_censor - Time to event variable for atrial fibrillation. Time (in days) from start of study to afib for event that occurred during study follow up; and follow up time for those that did not have an afib during study follow up (phv00190331.v3.p3)
  • ANALYTE_TYPE - Analyte type (phv00190395.v3.p3)
  • BODY_SITE - Body site where sample was collected (phv00190394.v3.p3)
  • chf_baseline - History of congestive heart failure (CHF) at first participant visit (phv00190328.v3.p3)
  • death - 0/1 to indicate that the participant died during study follow up (phv00190332.v3.p3)
  • death_tte_or_censor - Time to death or censoring time. Time (in days) from start of study to death for participants that died during study follow up; and follow up time for those that did not die during study follow up (phv00190333.v3.p3)
  • fasting_glucose - Blood fasting glucose at first participant visit in mg/dL (phv00190339.v3.p3)
  • fasting_insulin - Blood fasting insulin at first participant visit in uU/mL. (Note that there are some extreme outliers) (phv00190337.v3.p3)
  • htn_status_baseline - Hypertension status at first participant visit (0/1) (phv00190318.v3.p3)
  • imt_meanmean_farwall_ica - Average far wall thickness of the right and left internal carotid maximum intima media thickness IMT values, using as many views as are available for a given study (phv00190380.v3.p3)
  • IS_TUMOR - Tumor status (phv00190396.v3.p3)
  • lvh_at_ekg - Left ventriculat hypertrophy status at first participant visit (0/1) (phv00190386.v3.p3)
  • mi_during_followup - 0/1 to indicate that a myocardial infarction (MI) occurred during study follow up. 0 if no MI during study follow up. 1 if an adjudicated MI occurred during study follow up (even if baseline MI status was 1). (phv00190323.v3.p3)
  • mi_tte_or_censor - Time to event variable for myocardial infarction (MI). Time (in days) from start of study to MI for event that occurred during study follow up; and follow up time for those that did not have an MI during study follow up. (phv00190324.v3.p3)
  • SAMPLE_ID - De-identified sample ID (phv00190393.v4.p3)
  • stroke_baseline - History of stroke at first participant visit (0/1) (phv00190325.v3.p3)
  • stroke_during_followup - 0/1 to indicate that a stroke occurred during study follow up. 0 if no stroke during study follow up. 1 if an adjudicated stroke occurred during study follow up. (phv00190326.v3.p3)
  • stroke_tte_or_censor - Time to event variable for stroke. Time (in days) from start of study to stroke for event that occurred during study follow up; and follow up time for those that did not have an adjudicated stroke during study follow up. (phv00190327.v3.p3)
  • SUBJECT_ID - Participant ID submitted to dbGaP (phv00190300.v4.p3)
  • waist_baseline - Waist in cm. at first participant visit (phv00190308.v3.p3)
  • whr_baseline - Waist to hip ratio at first participant visit (phv00190309.v3.p3)
  • wpw_or_avblock2_at_ekg - Indicator (0/1) for Wolff-Parkinson-White pattern or second degree AV Block at EKG visit (phv00190387.v3.p3)